-
-
BARCELONA The treatment of cardiovascular disease in Europe is increasingly reliant upon interventional technologies, moving away from the use of open surgical techniques both for coronary and peripheral vascular disease.
-
ZURICH, Switzerland Medical devices are hot, said Carola Schropp, managing partner with the EBD Group (San Diego) in the opening address at BioDevice Partnering 2007 here in mid-June.
-
Medical Carbon Research Institute (Austin, Texas) last month was renamed On-X Life Technologies after Paul Capital Healthcare (New York) and several other existing investors provided $32 million through a combination of debt, revenue interest and royalty conversion, as well as a new equity capital infusion into the company.
-
Advanced Cell Technology; Mytogen; ATS Medical ; CryoCath Technologies; Corautus Genetics; VIA Pharmaceuticals; Flextronics International; Solectron; Greatbatch; Enpath Medical; MedCath; MedCath Partners Division; MedCath Diagnostics; New Hanover Regional Medical Center
-
Cambridge Heart; St. Jude Medical; Cardio3 BioSciences; Mayo Clinic; CAS Medical Systems ; Davis Marcus Partners; Cholestech; Onsite Health Diagnostics; Home Access Health; American Diabetes Association
-
AGA Medical; ATS Medical; Problem Solving Concepts; Spectranetics; Vasogen; Vidacare
-
HIV clinicians will have a powerful new weapon in the AIDS arsenal when the first CCR5 antagonist receives marketing approval from the Food and Drug Administration. Approval was expected to be given sometime in July or August.
-
For about two decades research data have suggested that genital herpes is a risk factor in HIV acquisition. But now there is a growing consensus among investigators that genital herpes may account for a significant proportion of new HIV infection, an expert says.
-
Current entry inhibitors under study, including maraviroc, target one of the three stages of HIV's entry into cells.
